These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 37068497)

  • 1. Can treatment-as-prevention and PrEP reduce HIV incidence?
    Phanuphak N; Phanuphak P
    Lancet HIV; 2023 Jun; 10(6):e355-e356. PubMed ID: 37068497
    [No Abstract]   [Full Text] [Related]  

  • 2. [PrEP for HIV prevention, major tool of the global diversified prevention strategy].
    Slama L
    Rev Prat; 2021 Nov; 71(9):957-959. PubMed ID: 35147307
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    LeVasseur MT; Goldstein ND; Tabb LP; Olivieri-Mui BL; Welles SL
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):31-40. PubMed ID: 28961679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added Benefits of Pre-Exposure Prophylaxis Use on HIV Incidence with Minimal Changes in Efficiency in the Context of High Treatment Engagement Among Men Who Have Sex with Men.
    Singleton AL; Marshall BDL; Zang X; Nunn AS; Goedel WC
    AIDS Patient Care STDS; 2020 Dec; 34(12):506-515. PubMed ID: 33216618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrogating the promise of long-acting HIV pre-exposure prophylaxis.
    Pike C; Bekker LG
    Trends Mol Med; 2023 Feb; 29(2):93-98. PubMed ID: 36435632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out.
    Marcus JL; Paltiel AD; Walensky RP
    Clin Infect Dis; 2020 Dec; 71(12):3152-3153. PubMed ID: 32097454
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis (HIV-PrEP) awareness in sexual health clinic attendees in Brighton, UK.
    Savary-Trathen A; Cooper R; Fitzpatrick C; Williams D; Richardson D
    Sex Transm Infect; 2023 May; 99(3):216. PubMed ID: 36754624
    [No Abstract]   [Full Text] [Related]  

  • 10. Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.
    Van Epps P; Wilson BM; Garner W; Beste LA; Maier MM; Ohl ME
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):427-430. PubMed ID: 31714421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV prevention with PrEP: Challenges and prospects].
    Guyonvarch O; Vaillant L; Hanslik T; Blanchon T; Rouveix E; Supervie V
    Rev Med Interne; 2021 Apr; 42(4):275-280. PubMed ID: 33127173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV PrEP and viral hepatitis: a unique opportunity for integration.
    Schaefer R; Schmidt HA; Rodolph M; Lesi O; Baggaley R; Luhmann N
    Lancet HIV; 2022 Nov; 9(11):e745. PubMed ID: 36332650
    [No Abstract]   [Full Text] [Related]  

  • 14. Equitable access to long-acting PrEP on the way?
    The Lancet Hiv
    Lancet HIV; 2022 Jul; 9(7):e449. PubMed ID: 35777403
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-exposure prophylaxis for South African adolescents: What evidence?
    Bekker LG; Gill K; Wallace M
    S Afr Med J; 2015 Nov; 105(11):907-11. PubMed ID: 26632316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV: Two in three people have trouble getting PrEP, finds survey.
    Griffin S
    BMJ; 2022 Nov; 379():o2667. PubMed ID: 36332912
    [No Abstract]   [Full Text] [Related]  

  • 18. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
    Jenness SM; Maloney KM; Smith DK; Hoover KW; Goodreau SM; Rosenberg ES; Weiss KM; Liu AY; Rao DW; Sullivan PS
    Am J Epidemiol; 2019 Apr; 188(4):743-752. PubMed ID: 30312365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
    Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.